The University of Texas at Dallas

Institutional Initiatives

The Texas Biomedical Device Center (TxBDC) at the University of Texas at Dallas consists of a world class team of scientists, engineers, medical doctors, regulatory specialists, and clinicians committed to the development of affordable and innovative therapies and technologies to improve the quality of life for individuals suffering from neurological disorders.

Conditions affecting the brain and nervous system are extremely common, debilitating, and incurable. No effective treatments currently exist to restore normalcy to these patients’ lives.

Our teams strive to understand the mechanisms responsible for learning and communication within the brain and nervous system. We develop technologies and therapies designed to detect even subtle changes in brain performance, quantify impairments, and ultimately direct healing by harnessing the neurological system’s natural ability to adapt and reorganize.

The Texas Biomedical Device Center has a vision: to make Dallas the world’s leader in treating neurological injury and disease. This initiative is based on ground breaking Targeted Plasticity Therapy developed by TxBDC researchers. This therapy has been shown to radically accelerate recovery and learning in multiple neurological injuries and diseases.

The Texas Biomedical Device Center, located in the Bioengineering Science Building at the University of Texas at Dallas, was established in April of 2012 with donations from Texas Instruments and a private donor. In the short time since its creation, the center has published over 80 peer reviewed publications, participated in 4 successful clinical trials for Targeted Plasticity Therapy, spun out 4 new advanced biomedical technologies to manufacturing companies and generated an additional $25 million in funding.

Stay In Touch

The Postsecondary Innovation Network is committed to innovation and collaboration to enhance educational opportunity and success for Texas students. Please subscribe to receive periodic updates about our collective work, institutional innovations and current policy issues.